🔴 Managing Heart Failure in Patients on Dialysis: State-of-the-Art Review⤵️ 🔹onlinejcf.com/article/S1071-… #cardiology #CardioEd

Congratulations to our stellar cardiology aspirants Subaina Khalid Taha Mansoor Ibraiz Bilal under the mentorship of Abdul Mannan Khan Minhas🫀📝

GWTG-HF data shows ~80% of patients with newly diagnosed #HFrEF are eligible for #quadtherapy yet 1/6 receive it. If prescribed, rapid initiation of #GDMT at the time of HF diagnosis yields large absolute mortality reductions. bit.ly/3Mn0oq7 Gregg Fonarow MD Steve Greene #JACCHF

Pooled analysis of patients with HFpEF in STEP-HFpEF, SELECT, and FLOW Mikhail Kosiborod Saint Luke's Mid America Heart Institute Saint Luke's Muthu Vaduganathan

From JAMA: Among patients who underwent major noncardiac surgery, renin-angiotensin system inhibitor continuation before surgery was not associated with a higher rate of postoperative complications than discontinuation. ja.ma/4e22mrI #ESCCongress

#PREMIER trial In-🏥 initiation of angiotensin receptor–neprilysin inhibition in acute heart failure 👥 400🇯🇵(median age 75 years, 31.9% women, de novo heart failure rate 55.6%, and median EF 37%) 👉% changes in NT-proBNP level geometric means at Weeks 4/8 were −35%/−45%

DCRI's Steve Greene will present on the importance of rapid treatment optimisation as part of a three step approach to treating patients with worsening heart failure in 15 minutes at #ESCCongress.

Packed room when Steve Greene preaches Time is Prognosis in HF #GDMT 🙌🏻

Presentation and publications #latebreaking The strategy was effective to 📈GDMT  #ESCCongress European Society of Cardiology @Rafavidalperez Nico Bruining EiC EHJ Digital Health HFAPresident @nature Wilfried Mullens Jozine ter Maaten Henry Han Gregg Fonarow MD Steve Greene Harriette Van Spall, MD MPH Victoria Delgado Charles Fauvel Novi Tham

🔴🔴Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction ⏰32 months 👉Finerenone ⬇️16%RR primary endpoint (CV💀/WHF) ⬇️12%RR total number of worsening heart failure events. 🔴No significant difference in CV💀 ⬆️ risk of hyperkalemia and a reduced

The FINEHEART Program - pre-specified individual participant data from FINEARTS, FIDELIO and FIGARO Presented by Muthu Vaduganathan #ESCCongress

FINEHEART: pooled analysis of the #finerenone phase 3 trials of FINEARTS, FIGARO & FIDELIO showed significant benefit in cardio & kidney outcomes in a broad population of patients with CKM conditions. #ESC2024. Excellent presentation by Muthu Vaduganathan .👏👏👏

No #cardiology meeting is complete without a recording of #DontMissABeat! In this episode, Muthu Vaduganathan plays the role of host and special guest as he discusses the meeting’s hottest topic, FINEARTS-HF, w/ Steve Greene. Episode out tomorrow! #ESCCongress #HeartFailure

Stay tuned for a very special episode of #DontMissABeat coming soon from #ESCCongress. Discussing all things #finerenone and #FINEARTS_HF. A deep dive into the latest therapeutic milestone for #HF and the practical implications for our patients. Muthu Vaduganathan #GDMTworks

MRA in HFrEF RALES 1999 ⬇️ ☠️ HR 0.70 (0.60-0.83) p<0.001 EMPHASIS-HF 2010 ⬇️ ☠️ HR 0.76 (0.62-0.93) p=0.008 Class 1 in guidelines for HFrEF Cost of Rx ~$40 per year Use in routine US clinical practice in eligible patients without CI/intolerance in 2024? <40% 🚨🚨🚨🚨🚨

This year’s CTCPR Trials & CIRL dinner at #ESC2024! We are increasing in size every year; this year was our largest ESC dinner ever (>40 people); including great friends and collaborators like avazir Harriette Van Spall, MD MPH Steve Greene Brittany Weber scottdavidsolomon Ankeet S. Bhatt, MD, MBA Sheila Hegde Nochioka Kotaro

See Steve Greene in 15 minutes present on the clinical and finical implications of worsening heart failure management strategies at #ESCCongress.

Can't get enough of FINEARTS-HF or maybe you're wondering what it means for spironolactone? Check out the latest episode of #DontMissABeat where Muthu Vaduganathan and Steve Greene break down the trial, results, and future research priorities. hcplive.com/view/dont-miss… #ESCCongress

Really nice break down of trial design and clinical perspectives by two outstanding trialists and cardiologists Steve Greene Muthu Vaduganathan Highly recommended POD for research-inclined FITs #ACCFIT CardioNerds #DontMissABeat

🔴 From Hospital to Home: Evidence-Based Care for Worsening Heart Failure JACC Journals #CardioEd #Cardiology #CardioTwitter